Syneron Medical has introduced LipoLite, following the FDA approval for laser-assisted lipolysis and additional dermatological procedures.
Subscribe to our email newsletter
For patients, LipoLite is both a minimally invasive alternative and a complement to traditional liposuction fat-removing procedures. According to the company, the procedure requires only local anesthetic and is designed to provide patients lasting results with little downtime and a high level of safety.
For physicians, the small, compact LipoLite system is comfortable to use, upgradeable to support future applications and fits easily on tabletops to save floor space in small operating rooms where space can be at a premium.
Doron Gerstel, CEO of Syneron, said: “We are confident that with the combination of Syneron’s existing Vela product lineup and this new lipolysis device our physician partners will be able to offer a more well-rounded aesthetic service package to patients and we at Syneron will continue to provide our doctors with more options for success.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.